Aims and Scope

The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) is an international, peer-reviewed, open-access journal, which was founded in Dec 2009. JTD is indexed by Science Citation Index Expanded (SCIE), PubMed/PubMed Central and Scopus. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-). JTD received its impact factor of 2.895 for the year 2020. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.

Information for Authors

JTD is a member of Committee on Publication Ethics (COPE) and it follows the Committee on Publication Ethics (COPE)'s guidelines and the ICMJE recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journal.

Manuscripts submitted must be the original work of the author(s) and must not be published previously or under consideration for publication elsewhere.

Submission Turnaround Time

In-house review: 1-3 weeks

External peer review: 1-3 months

Publication Ahead of Print: within 1 month after being accepted

Formal publication: within 1-3 months after being accepted. Original Articles are listed as priority.

JTD is the official publication of:

China State Key Laboratory of Respiratory Disease

Guangzhou Institute of Respiratory Health (GIRH)

The First Affiliated Hospital of Guangzhou Medical University

The Society of Translational Medicine (STM)

JTD is endorsed by:

International COPD Coalition (ICC)

China Asthma Alliance (CAA)

Global Alliance against Chronic Respiratory Diseases (GARD)

Publisher Information

JTD is published by AME Publishing Company.

Address: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.